Dr. Marie-Paule Richard to Join AiCuris as CMO
AiCuris announced that Dr. Marie-Paule Richard has assumed the responsibility of Chief Medical Officer at AiCuris, Germany. Dr. Richard has over 24 years of experience in the pharmaceutical industry in leading global clinical development projects, supervising clinical-regulatory strategies, clinical operations, pharmacovigilance, medical affairs, and managing multicultural and cross-functional teams and departments. She has been responsible for the global development of a large number of anti-infectives and vaccines that she led successfully to international registrations.
After six years at Bristol-Myers Squibb as a medical-marketing Manager, Dr Richard joined Aventis Pharma as European Clinical Project Manager in a French-Japanese joint-venture, then as Director in the global anti-infectives corporate clinical department. In 2000, she joined GlaxoSmithKline in the UK as Sr Director with responsibility for a portfolio of anti-infectives. Thereafter Dr Richard was appointed VP Clinical Development in Sanofi Pasteur France . From 2008, she was a Medical Advisor for several biotech companies in Switzerland and France, and for a Capital Venture Fonds.
Dr. Richard is an M.D., she received her diploma in clinical immunology, pharmacology/ pharmacokinetics, and an MBA from CEDEP-INSEAD.
Most read news
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.